Shandong Lukang Pharmaceutical Co (SHSE:600789) Cyclically Adjusted PB Ratio: (As of Aug. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600789 Shandong Lukang Pharmaceutical Co Ltd SHSE:600789
69 GF Score
Price ¥7.76
GF Value ¥7.55
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Shandong Lukang Pharmaceutical Co Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Shandong Lukang Pharmaceutical Co  (SHSE:600789) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Shandong Lukang Pharmaceutical Co Cyclically Adjusted PB Ratio Related Terms


Shandong Lukang Pharmaceutical Co Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Shandong Lukang Pharmaceutical Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Lukang Pharmaceutical Co Cyclically Adjusted PB Ratio Chart

Shandong Lukang Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.54 2.32 2.18 2.74 2.45

Shandong Lukang Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.80 2.68 2.45 2.21 0.00

SHSE:600789 vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Shandong Lukang Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Lukang Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Lukang Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shandong Lukang Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


SHSE:600789
69GF Score
Shandong Lukang Pharmaceutical Co Ltd SHSE:600789
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Lukang Pharmaceutical Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Shandong Lukang Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Shandong Lukang Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4.955/116.0564*116.0564
=4.955

Current CPI (Jun. 2026) = 116.0564.

Shandong Lukang Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 2.453 102.400 2.780
201612 2.454 102.600 2.776
201703 2.471 103.200 2.779
201706 2.481 103.100 2.793
201709 2.496 104.100 2.783
201712 2.590 104.500 2.876
201803 3.321 105.300 3.660
201806 3.332 104.900 3.686
201809 3.332 106.600 3.628
201812 3.324 106.500 3.622
201903 3.380 107.700 3.642
201906 3.394 107.700 3.657
201909 3.417 109.800 3.612
201912 3.432 111.200 3.582
202003 3.439 112.300 3.554
202006 3.694 110.400 3.883
202009 3.655 111.700 3.798
202012 3.651 111.500 3.800
202103 3.710 112.662 3.822
202106 3.734 111.769 3.877
202109 3.752 112.215 3.880
202112 3.728 113.108 3.825
202203 3.751 114.335 3.807
202206 3.777 114.558 3.826
202209 3.762 115.339 3.785
202212 3.785 115.116 3.816
202303 3.844 115.116 3.875
202306 3.938 114.558 3.990
202309 3.959 115.339 3.984
202312 4.031 114.781 4.076
202403 4.106 115.227 4.136
202406 4.295 114.781 4.343
202409 4.332 115.785 4.342
202412 4.360 114.893 4.404
202503 4.446 115.116 4.482
202506 4.389 114.907 4.433
202509 3.786 115.471 3.805
202512 4.894 115.832 4.903
202603 4.944 116.303 4.934
202606 4.955 116.056 4.955

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Shandong Lukang Pharmaceutical Co (SHSE:600789) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Lukang Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥7.76 is trading 2.8% above its estimated GF Value™ of ¥7.55. GuruFocus considers Shandong Lukang Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:600789:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: ¥7.55 vs. price of ¥7.76 (2.8% above fair value)
  • GF Score™: 69/100 with 7 warning signs

No single metric tells the full story. See the SHSE:600789 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shandong Lukang Pharmaceutical Co Business Description

Address No. 152 Taibai West Road, Jining, Shandong, CHN, 272021
Shandong Lukang Pharmaceutical Co Ltd is a bio-pharmaceuticals company. It is engaged in manufacturing antibiotics, semi-synthetic antibiotics for human use, bio-pharmaceuticals for veterinary and agriculture use, intermediates, resins, starches, glucose and amino acids.
69GF Score

Get the complete analysis for SHSE:600789

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥7.76
Price
¥7.55
GF Value